(Q35676891)

9 August 2017

1 reference

title

Eating disorders, serotonin transporter polymorphisms and potential treatment response (English)

1 reference

9 August 2017

1 reference

Philip Gorwood

1

1 reference

9 August 2017

1 January 2004

1 reference

Molecular Diagnosis and Therapy

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

1

1 reference

9 August 2017

9-17

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500219

9 August 2017

0 references

cites work

Ethical and legal implications of pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Pharmacogenetics: the ethical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Racial differences in the response to drugs--pointers to genetic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Racial Profiling in Medical Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

The importance of race and ethnic background in biomedical research and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Pharmacogenetics, race, and ethnicity: social identities and individualized medical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Pharmacogenetics and future drug development and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Pharmacogenetics in the laboratory and the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Pharmacogenomics: the future of drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Consent and privacy in pharmacogenetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Informed consent for population-based research involving genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

A model agreement for genetic research in socially identifiable populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Ethics. Protecting communities in biomedical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Protecting communities in research: current guidelines and limits of extrapolation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Medical and scientific uses of human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Jewish leaders seek genetic guidelines⃛

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

Pharmacogenomics: ethical concerns for research and pharmacy practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

7 January 2021

Pharmacogenetics: ethical issues and policy options

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

7 January 2021

Pharmacogenomics and the (ir)relevance of race

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

7 January 2021

Pharmacogenetics and the future of medical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

7 January 2021

Pharmacogenetic challenges for the health care system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

7 January 2021

Protecting communities in research: philosophical and pragmatic challenges.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

7 January 2021

Participatory research with native community of Kahnawake creates innovative Code of Research Ethics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500219

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500219

1 reference

9 August 2017

1 reference

PubMed ID

14987118